Treanda

FDA Building

Pharma

Treanda copycat delay shows FDA trapped by orphan drug rules

The FDA tacked three extra years of generic-free sales onto Eagle Pharma's Treanda after a court-granted sister drug Bendeka orphan drug exclusivity.

Angus Liu Feb 26, 2019 12:17pm

Don't blame PBM rebates for all price hikes, analyst says

Jul 6, 2017 10:03am

Teva

Teva eyes debt-cutting sale of its cancer meds

Apr 26, 2017 11:40am